Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall

Nordestgaard, B G, Stender, S, Kjeldsen, K·1988·Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
DOI 10.1161/01.atv.8.4.421

Cited by (137)

Items 101–137 of 137

  1. Effects of diabetes and CETP expression on diet‐induced atherosclerosis in LDL receptor‐deficient mice
    Jairo Augusto Berti, Alessandro Gonzalez Salerno, E.J.B. Bighetti, A.C. Casquero, Antonio Carlos Boschero, Helena C.F. Oliveira · 2005 · Apmis
  2. In the Beginning, Lipoproteins Cross the Endothelial Barrier
    Ira J. Goldberg, Ainara G. Cabodevilla, Waqas Younis · 2024 · Journal of Atherosclerosis and Thrombosis
  3. Why, when and how should hypertriglyceridemia be treated in the high-risk cardiovascular patient?
    Gerald Francis Watts, Fredrik Karpe · 2011 · Expert Review of Cardiovascular Therapy
  4. The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits
    CYNTHIA M. ARBEENY, Kristin E. Bergquist · 1991 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  5. Cardiovascular structure and function in baboons with Type 1 diabetes — a transvenous ultrasound study
    Upul Premawardhana, Mark R. Adams, Alexandra M. Birrell, Dennis K. Yue, David Stephen Celermajer · 2001 · Journal of Diabetes and its Complications
  6. A New Start for Triglycerides and Remnant Cholesterol—Nonfasting
    Børge Grønne Nordestgaard · 2017 · Clinical Chemistry
  7. Discrepant association of serum C-3 epimer of 25-hydroxyvitamin D versus non-epimeric 25-hydroxyvitamin D with serum lipid levels
    La‐or Chailurkit, Wichai Aekplakorn, Kriangsuk Srijaruskul, Boonsong Ongphiphadhanakul · 2016 · Lipids in Health and Disease
  8. Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice
    Ainara G. Cabodevilla, María Concepción Izquierdo, Debapriya Basu, Waqas Younis, Munichandra Babu Tirumalasetty, Qing Robert Miao, Dimitris Nasias, Jenny E. Kanter, Tse Wing Winnie Ho, Jana Gjini et al. · 2026 · Nature Communications
  9. Lipids and cardiovascular disease 3 Triglycerides and cardiovascular disease
    Børge Grønne Nordestgaard, Anette Varbo · 2014
  10. Hypertriglyceridemia: Is there a role for prophylactic apheresis? A case report
    Ana Rita Francisco, Inês Santos Gonçalves, Fátima Veiga, Mónica Mendes Pedro, Fausto José Pinto, Dulce A. Brito · 2016 · Brazilian Journal of Nephrology
  11. Aortic esterified cholesterol is not superior to total cholesterol as a measure of atherosclerosis severity in cholesterol-fed rabbits
    L NIELSEN, Børge Grønne Nordestgaard, Steen Stender · 1993 · Atherosclerosis
  12. Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside
    Henry N. Ginsberg, Karin Bornfeldt · 2026 · Circulation Research
  13. Triglycérides et risque cardiovasculaire
    René Valéro · 2019 · Médecine des Maladies Métaboliques
  14. ATVB In Focus
    Richard Alan Cohen · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
  15. Commentary: Nonfasting remnant cholesterol simplifies triglyceride-rich lipoproteins for clinical use, and metabolomic phenotyping ignites scientific curiosity
    Anette Varbo, Anne Langsted, Børge Grønne Nordestgaard · 2016 · International Journal of Epidemiology
  16. Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons
    Mia Ø Johansen, Signe Vedel‐Krogh, Sune Fallgaard Nielsen, Shoaib Afzal, George Davey Smith, Børge Grønne Nordestgaard · 2025 · Atherosclerosis
  17. Association between postprandial lipoprotein subclasses and Framingham cardiovascular disease risk stratification
    Chun Gu, Na Wang, Peng Ren, Xuemei Wu, Bo Pang, Shuying Zhang, Xueyun Hou, Dan Xu, Yuliang Yuan, Guijian Liu · 2020 · Clinical Biochemistry
  18. The Use of Animal Models to Study Diabetes and Atherosclerosis and Potential Anti-Atherosclerotic Therapies
    Peter D. Reaven, Wulf Palinski · 2005 · Humana Press eBooks
  19. Triglyceride-rich Lipoprotein Cholesterol (Remnant Cholesterol) as a Therapeutic Target for Cardiovascular Disease Risk
    Børge Grønne Nordestgaard, Anette Varbo · 2020 · Contemporary cardiology
  20. Hipertrigliceridemia (> 150 mg/dl) como marcador de riesgo cardiovascular
    José López-Miranda · 2025 · Clínica e Investigación en Arteriosclerosis
  21. OS TIPOS DE TRATAMENTOS ATUALMENTE DISPONÍVEIS PARA DISLIPIDEMIA E CONTROLE DOS TRIGLICERÍDEOS
    Daniela Rodrigues Nogueira, Gabriel Chehab de Carvalho Melo, Ivy de Almeida Cavalcante e Silva, Luiz Eduardo Pinheiro Moreira, Magda de Souza Barbeiro Pedrosa, Márcia de Paula Cardinali, Priscylla Lima Viscone Peron, Roberta Gomes Piazzi · 2024 · EPITAYA eBooks
  22. Disminución de triglicéridos sin ayuno y reducción de mortalidad por cualquier causa: un estudio de randomización mendeliana
    Mikkel Jacobi Thomsen, Anette Varbo, Anne Tybjærg‐Hansen, Børge Grønne Nordestgaard · 2014 · Redalyc (Universidad Autónoma del Estado de México)
  23. Pathobiology of Atherosclerosis
    Alain Tedgui, Catherine Bernard, Ziad Mallat · 1999 · Basic science for the cardiologist
  24. Egyptian practical guidance in hypertriglyceridemia management 2021
    Hesham Salah El Din Taha, H. Kandil, N. Farag, A. Oraby, M. E. El Sharkawy, Fouad Fawzy, H. Mahrous, Juliette Bahgat, M. Samy, Mohamed Aboul et al. · 2021 · Egyptian Heart Journal
  25. Hypertriglyceridemia (> 150 mg/dL) as a marker of cardiovascular risk
    José López-Miranda · 2025 · Clínica e Investigación en Arteriosclerosis (English Edition)
  26. Triglyceride-Rich Lipoproteins and Inflammation: Independent and Synergistic Roles in Cardiovascular Disease
    A G Nordestgaard · 2026 · Current Atherosclerosis Reports
  27. The perlecan LDL-binding receptor needs sugar: Implication of perlecan core protein interaction with LDL for atherosclerosis
    2015 · Receptors & Clinical Investigation
  28. Animal Models of Diabetes and Atherosclerosis
    Peter D. Reaven, Wulf Palinski · 2001 · Humana Press eBooks
  29. Atherogenesis and the Role of Lipoproteins
    Steen Stender · 1990 · Scandinavian Journal of Clinical and Laboratory Investigation
  30. Hyperlipidemia: Pathogenesis and Management in Diabetes Mellitus
    Ira J. Goldberg · 2004 · Springer eBooks
  31. Relação da lipemia pós prandial com aterosclerose avaliada pela angiotomografia coronária
    Programa de Cardiologia · 2013
  32. The final word about LDL-cholesterol lowering
    Dan A. Streja · 2018 · Current Opinion in Endocrinology Diabetes and Obesity
  33. Role of lipoprotein lipase variants in metabolic disorders and cardiovascular diseases
    Sana Rafaqat, Saira Rafaqat, Saima Sharif, Aleksandra N. Klisic · 2024 · Arhiv za farmaciju
  34. Additional file 1 of Nonlinear connection between remnant cholesterol and stroke risk: evidence from the China health and retirement longitudinal study
    Wang, Yuanqing, Zha, Fubing, Yong Yun Han, Cai, Ying, Chen, Miaoling, Yang, Cui, Cai, Xiaodong, Hu, Haofei, Cao, Changchun, Luo, Jiao · 2023 · Figshare
  35. Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease
    Anders Berg Wulff, Anette Varbo, A G Nordestgaard, Børge Grønne Nordestgaard · 2026 · Expert Opinion on Therapeutic Targets
  36. Clinical Assessment of Anti-Atherogenic Function of HighDensity Lipoprotein (HDL)
    Feng Ma · 2018 · theses.fr (ABES)
  37. Omics of human plasma lipoproteins : role in cardiometabolic diseases
    Emil Zakiev · 2019 · theses.fr (ABES)